Group 1 - The core viewpoint of the article is that He Yuan Bio (688765) has officially launched its issuance work, becoming the first company to start this process after the resumption of the fifth set of standards for the Sci-Tech Innovation Board [1] - He Yuan Bio is an innovative biopharmaceutical company with a globally leading plant bioreactor technology platform [1] - The company is the first to adopt differentiated lock-up and allocation arrangements for offline issuance under the relevant pilot arrangements of the "Eight Articles of the Sci-Tech Innovation Board" [1] Group 2 - According to the prospectus, the overall lock-up ratio for offline issuance is no less than 40% [1] - The company has set three tiers of differentiated lock-up levels for investor quotations, with the allocation ratio for the highest lock-up tier being no less than nine times that of the lowest lock-up tier [1]
禾元生物成首家启动发行的科创成长层新注册企业
Bei Jing Shang Bao·2025-09-22 13:09